Interacting Drugs |
Vinblastine vs MitoMYcin |
Security Level |
 |
Mechanism |
MitoMYcin: Antineoplastic Agents (Vinca Alkaloids) may enhance the adverse/toxic effect of MitoMYcin. Specifically, the risk of pulmonary toxicity may be increased. |
Management |
Monitor therapy |
Vinblastine vs MitoMYcin
Post Review about Vinblastine vs MitoMYcin Click here to cancel reply.
Other Interactions of Vinblastine
Other Interactions of MitoMYcin
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.